Curcumin clarithromycin nano-form a promising agent to fight Helicobacter pylori infections
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Curcumin clarithromycin nano-form a promising agent to fight Helicobacter pylori infections ; volume:39 ; number:12 ; day:29 ; month:9 ; year:2023 ; pages:1-18 ; date:12.2023
World journal of microbiology and biotechnology ; 39, Heft 12 (29.9.2023), 1-18, 12.2023
- Urheber
-
Mosallam, Farag M.
Bendary, Mahmoud M.
Elshimy, Rana
El-Batal, Ahmed I.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s11274-023-03745-7
- URN
-
urn:nbn:de:101:1-2024012213265159943884
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:32 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Mosallam, Farag M.
- Bendary, Mahmoud M.
- Elshimy, Rana
- El-Batal, Ahmed I.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Therapie der Helicobacter pylori-Infektion bei Patienten mit gegen Metronidazol und Clarithromycin doppelresistenten Helicobacter pylori-Stämmen
Cyclooxygenase inhibition with curcumin in Helicobacter pylori infection
Mutant selection window of clarithromycin for clinical isolates of Helicobacter pylori
Detection of Clarithromycin Resistance in Helicobacter pylori Using MmaxSure™ H. pylori & ClaR Assay
Prevalence of Clarithromycin-Resistant Helicobacter pylori Strains in Zambia: A Sub-Saharan African Country
Phenotypic and genotypic correlation as expressed in Helicobacter pylori resistance to clarithromycin and fluoroquinolones
Helicobacter pylori
Prevalence of clarithromycin-resistant Helicobacter pylori strains in gastric mucosa-associated lymphoid tissue lymphoma patients
Highly clarithromycin-resistant Helicobacter pylori infection in asymptomatic children from a rural community of Cajamarca-Peru
Low rate of recurrence of Helicobacter Pylori infection in spite of high clarithromycin resistance in Pakistan
Levofloxacin versus clarithromycin for Helicobacter pylori eradication: are 14 day regimens better than 10 day regimens?
PNA-FISH as a new diagnostic method for the determination of clarithromycin resistance of Helicobacter pylori
Therapie der Helicobacter pylori-Infektion bei Patienten mit gegen Metronidazol und Clarithromycin doppelresistenten Helicobacter pylori-Stämmen
Cyclooxygenase inhibition with curcumin in Helicobacter pylori infection
Mutant selection window of clarithromycin for clinical isolates of Helicobacter pylori
Detection of Clarithromycin Resistance in Helicobacter pylori Using MmaxSure™ H. pylori & ClaR Assay
Prevalence of Clarithromycin-Resistant Helicobacter pylori Strains in Zambia: A Sub-Saharan African Country
Phenotypic and genotypic correlation as expressed in Helicobacter pylori resistance to clarithromycin and fluoroquinolones
Helicobacter pylori
Prevalence of clarithromycin-resistant Helicobacter pylori strains in gastric mucosa-associated lymphoid tissue lymphoma patients
Highly clarithromycin-resistant Helicobacter pylori infection in asymptomatic children from a rural community of Cajamarca-Peru
Low rate of recurrence of Helicobacter Pylori infection in spite of high clarithromycin resistance in Pakistan
Levofloxacin versus clarithromycin for Helicobacter pylori eradication: are 14 day regimens better than 10 day regimens?
PNA-FISH as a new diagnostic method for the determination of clarithromycin resistance of Helicobacter pylori
Therapie der Helicobacter pylori-Infektion bei Patienten mit gegen Metronidazol und Clarithromycin doppelresistenten Helicobacter pylori-Stämmen
Cyclooxygenase inhibition with curcumin in Helicobacter pylori infection
Mutant selection window of clarithromycin for clinical isolates of Helicobacter pylori
Detection of Clarithromycin Resistance in Helicobacter pylori Using MmaxSure™ H. pylori & ClaR Assay
Prevalence of Clarithromycin-Resistant Helicobacter pylori Strains in Zambia: A Sub-Saharan African Country
Phenotypic and genotypic correlation as expressed in Helicobacter pylori resistance to clarithromycin and fluoroquinolones
Helicobacter pylori
Prevalence of clarithromycin-resistant Helicobacter pylori strains in gastric mucosa-associated lymphoid tissue lymphoma patients
Highly clarithromycin-resistant Helicobacter pylori infection in asymptomatic children from a rural community of Cajamarca-Peru
Low rate of recurrence of Helicobacter Pylori infection in spite of high clarithromycin resistance in Pakistan
Levofloxacin versus clarithromycin for Helicobacter pylori eradication: are 14 day regimens better than 10 day regimens?